QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

Search

Merck KGaA

Aperta

SettoreSettore sanitario

112 -2.9

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

111.9

Massimo

116.05

Metriche Chiave

By Trading Economics

Entrata

-83M

652M

Vendite

-25M

5.3B

EPS

2.07

Rendimento da dividendi

1.34

Margine di Profitto

12.407

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+17.72% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.34%

2.37%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

98B

Apertura precedente

114.9

Chiusura precedente

112

Notizie sul Sentiment di mercato

By Acuity

24%

76%

55 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Merck KGaA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 nov 2025, 13:40 UTC

Utili

Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update

13 nov 2025, 06:24 UTC

Utili

Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units

1 ott 2025, 08:54 UTC

I principali Market Mover

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

13 nov 2025, 07:57 UTC

Discorsi di Mercato
Utili

Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Says Guidance Midpoint Remains Unchanged

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Sees 2025 Organic Sales Growth of Around 3%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA 3Q After-Tax Profit EUR898M

13 nov 2025, 06:00 UTC

Utili

Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Narrows 2025 View

13 nov 2025, 06:00 UTC

Utili

Analysts Saw Merck KGaA 3Q Net Sales at EUR5.23B

13 nov 2025, 06:00 UTC

Utili

Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.67B

13 nov 2025, 06:00 UTC

Utili

Analysts Saw Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.56B

13 nov 2025, 06:00 UTC

Utili

Merck KGaA 3Q Sales EUR5.32B

6 nov 2025, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6 nov 2025, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

16 ott 2025, 08:34 UTC

Discorsi di Mercato

Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk

15 ott 2025, 12:08 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA Didn't Disclose Financial Details

15 ott 2025, 12:07 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio

15 ott 2025, 12:07 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: Unit is Based in Belgium, Has 50+ Employees

15 ott 2025, 12:06 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market

15 ott 2025, 12:05 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: Definitive Agreement Signed Today

15 ott 2025, 12:05 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA: Transaction Expected to Close by End of 2Q 2026

15 ott 2025, 12:04 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA to Buy Chromatography Business JSR Life Sciences

15 ott 2025, 12:03 UTC

Acquisizioni, Fusioni, Takeovers

Merck KGaA to Buy Chromatography Business of JSR Life Sciences

7 ago 2025, 08:04 UTC

Discorsi di Mercato
Utili

Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk

Confronto tra pari

Modifica del prezzo

Merck KGaA Previsione

Obiettivo di Prezzo

By TipRanks

17.72% in crescita

Previsioni per 12 mesi

Media 138.38 EUR  17.72%

Alto 182 EUR

Basso 105 EUR

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Merck KGaA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

9 ratings

5

Acquista

3

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

121.15 / 123.55Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Neutral Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

55 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Merck KGaA

There is no Profile data available for MRK.BE.
help-icon Live chat